Cargando…

Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50–60 kg/m(2): 5-year outcomes of a double-blind, randomized clinical trial

BACKGROUND: The optimal surgical weight loss procedure for patients with a BMI of 50 kg/m(2) or more is uncertain. This study compared distal Roux-en-Y gastric bypass (RYGB) with standard RYGB. METHODS: In this double-blind RCT, patients aged 18–60 years with a BMI of 50–60 kg/m(2) were allocated ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Salte, Odd Bjørn Kjeldaas, Svanevik, Marius, Risstad, Hilde, Hofsø, Dag, Blom-Høgestøl, Ingvild Kristine, Johnson, Line Kristin, Fagerland, Morten Wang, Kristinsson, Jon, Hjelmesæth, Jøran, Mala, Tom, Sandbu, Rune
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599874/
https://www.ncbi.nlm.nih.gov/pubmed/34791048
http://dx.doi.org/10.1093/bjsopen/zrab105
_version_ 1784601036274532352
author Salte, Odd Bjørn Kjeldaas
Svanevik, Marius
Risstad, Hilde
Hofsø, Dag
Blom-Høgestøl, Ingvild Kristine
Johnson, Line Kristin
Fagerland, Morten Wang
Kristinsson, Jon
Hjelmesæth, Jøran
Mala, Tom
Sandbu, Rune
author_facet Salte, Odd Bjørn Kjeldaas
Svanevik, Marius
Risstad, Hilde
Hofsø, Dag
Blom-Høgestøl, Ingvild Kristine
Johnson, Line Kristin
Fagerland, Morten Wang
Kristinsson, Jon
Hjelmesæth, Jøran
Mala, Tom
Sandbu, Rune
author_sort Salte, Odd Bjørn Kjeldaas
collection PubMed
description BACKGROUND: The optimal surgical weight loss procedure for patients with a BMI of 50 kg/m(2) or more is uncertain. This study compared distal Roux-en-Y gastric bypass (RYGB) with standard RYGB. METHODS: In this double-blind RCT, patients aged 18–60 years with a BMI of 50–60 kg/m(2) were allocated randomly to receive standard (150 cm alimentary, 50 cm biliopancreatic limb) or distal (150 cm common channel, 50 cm biliopancreatic limb) RYGB. The primary outcome (change in BMI at 2 years) has been reported previously. Secondary outcomes 5 years after surgery, such as weight loss, health-related quality of life, and nutritional outcomes are reported. RESULTS: Between May 2011 and April 2013, 123 patients were randomized, 113 received an intervention, and 92 attended 5-year follow-up. Mean age was 40 (95 per cent c.i. 38 to 41) years and 73 patients (65 per cent) were women; 57 underwent standard RYGB and 56 distal RYGB. BMI was reduced by 15.1 (95 per cent c.i. 13.9 to 16.2) kg/m(2) after standard and 15.7 (14.5 to 16.9) kg/m(2) after distal RYGB; the between-group difference was −0.64 (−2.3 to 1.0) kg/m(2) (P = 0.447). Total cholesterol, low-density lipoprotein cholesterol, and haemoglobin A1c levels declined more after distal than after standard RYGB. High-density lipoprotein cholesterol levels increased more after standard RYGB. Vitamin A and vitamin D levels were lower after distal RYGB. Changes in bone mineral density, resting metabolic rate, and total energy intake were comparable. CONCLUSION: Distal RYGB did not enable greater weight loss than standard RYGB. Differences in other outcomes favouring distal RYGB may not justify routine use of this procedure in patients with a BMI of 50–60 kg/m(2). Registration number: NCT00821197 (http://www.clinicaltrials.gov). Presented in part as abstract to the IFSO (International Federation for the Surgery of Obesity and Metabolic disorders) conference, Madrid, Spain, August 2019.
format Online
Article
Text
id pubmed-8599874
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85998742021-11-18 Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50–60 kg/m(2): 5-year outcomes of a double-blind, randomized clinical trial Salte, Odd Bjørn Kjeldaas Svanevik, Marius Risstad, Hilde Hofsø, Dag Blom-Høgestøl, Ingvild Kristine Johnson, Line Kristin Fagerland, Morten Wang Kristinsson, Jon Hjelmesæth, Jøran Mala, Tom Sandbu, Rune BJS Open Randomized Clinical Trial BACKGROUND: The optimal surgical weight loss procedure for patients with a BMI of 50 kg/m(2) or more is uncertain. This study compared distal Roux-en-Y gastric bypass (RYGB) with standard RYGB. METHODS: In this double-blind RCT, patients aged 18–60 years with a BMI of 50–60 kg/m(2) were allocated randomly to receive standard (150 cm alimentary, 50 cm biliopancreatic limb) or distal (150 cm common channel, 50 cm biliopancreatic limb) RYGB. The primary outcome (change in BMI at 2 years) has been reported previously. Secondary outcomes 5 years after surgery, such as weight loss, health-related quality of life, and nutritional outcomes are reported. RESULTS: Between May 2011 and April 2013, 123 patients were randomized, 113 received an intervention, and 92 attended 5-year follow-up. Mean age was 40 (95 per cent c.i. 38 to 41) years and 73 patients (65 per cent) were women; 57 underwent standard RYGB and 56 distal RYGB. BMI was reduced by 15.1 (95 per cent c.i. 13.9 to 16.2) kg/m(2) after standard and 15.7 (14.5 to 16.9) kg/m(2) after distal RYGB; the between-group difference was −0.64 (−2.3 to 1.0) kg/m(2) (P = 0.447). Total cholesterol, low-density lipoprotein cholesterol, and haemoglobin A1c levels declined more after distal than after standard RYGB. High-density lipoprotein cholesterol levels increased more after standard RYGB. Vitamin A and vitamin D levels were lower after distal RYGB. Changes in bone mineral density, resting metabolic rate, and total energy intake were comparable. CONCLUSION: Distal RYGB did not enable greater weight loss than standard RYGB. Differences in other outcomes favouring distal RYGB may not justify routine use of this procedure in patients with a BMI of 50–60 kg/m(2). Registration number: NCT00821197 (http://www.clinicaltrials.gov). Presented in part as abstract to the IFSO (International Federation for the Surgery of Obesity and Metabolic disorders) conference, Madrid, Spain, August 2019. Oxford University Press 2021-11-17 /pmc/articles/PMC8599874/ /pubmed/34791048 http://dx.doi.org/10.1093/bjsopen/zrab105 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Randomized Clinical Trial
Salte, Odd Bjørn Kjeldaas
Svanevik, Marius
Risstad, Hilde
Hofsø, Dag
Blom-Høgestøl, Ingvild Kristine
Johnson, Line Kristin
Fagerland, Morten Wang
Kristinsson, Jon
Hjelmesæth, Jøran
Mala, Tom
Sandbu, Rune
Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50–60 kg/m(2): 5-year outcomes of a double-blind, randomized clinical trial
title Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50–60 kg/m(2): 5-year outcomes of a double-blind, randomized clinical trial
title_full Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50–60 kg/m(2): 5-year outcomes of a double-blind, randomized clinical trial
title_fullStr Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50–60 kg/m(2): 5-year outcomes of a double-blind, randomized clinical trial
title_full_unstemmed Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50–60 kg/m(2): 5-year outcomes of a double-blind, randomized clinical trial
title_short Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50–60 kg/m(2): 5-year outcomes of a double-blind, randomized clinical trial
title_sort standard versus distal roux-en-y gastric bypass in patients with bmi 50–60 kg/m(2): 5-year outcomes of a double-blind, randomized clinical trial
topic Randomized Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599874/
https://www.ncbi.nlm.nih.gov/pubmed/34791048
http://dx.doi.org/10.1093/bjsopen/zrab105
work_keys_str_mv AT salteoddbjørnkjeldaas standardversusdistalrouxenygastricbypassinpatientswithbmi5060kgm25yearoutcomesofadoubleblindrandomizedclinicaltrial
AT svanevikmarius standardversusdistalrouxenygastricbypassinpatientswithbmi5060kgm25yearoutcomesofadoubleblindrandomizedclinicaltrial
AT risstadhilde standardversusdistalrouxenygastricbypassinpatientswithbmi5060kgm25yearoutcomesofadoubleblindrandomizedclinicaltrial
AT hofsødag standardversusdistalrouxenygastricbypassinpatientswithbmi5060kgm25yearoutcomesofadoubleblindrandomizedclinicaltrial
AT blomhøgestølingvildkristine standardversusdistalrouxenygastricbypassinpatientswithbmi5060kgm25yearoutcomesofadoubleblindrandomizedclinicaltrial
AT johnsonlinekristin standardversusdistalrouxenygastricbypassinpatientswithbmi5060kgm25yearoutcomesofadoubleblindrandomizedclinicaltrial
AT fagerlandmortenwang standardversusdistalrouxenygastricbypassinpatientswithbmi5060kgm25yearoutcomesofadoubleblindrandomizedclinicaltrial
AT kristinssonjon standardversusdistalrouxenygastricbypassinpatientswithbmi5060kgm25yearoutcomesofadoubleblindrandomizedclinicaltrial
AT hjelmesæthjøran standardversusdistalrouxenygastricbypassinpatientswithbmi5060kgm25yearoutcomesofadoubleblindrandomizedclinicaltrial
AT malatom standardversusdistalrouxenygastricbypassinpatientswithbmi5060kgm25yearoutcomesofadoubleblindrandomizedclinicaltrial
AT sandburune standardversusdistalrouxenygastricbypassinpatientswithbmi5060kgm25yearoutcomesofadoubleblindrandomizedclinicaltrial